Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Integra Lifesciences HoldingsIART +2.01%70 Days Inventory is 257.62 as of Mar. 2026, which is 27% above its 10-year median of 202.29. GuruFocus rates IART with a GF Score™ of 70/100 and a GF Value™ of $23.81 (Modestly Undervalued). The stock has 11 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Integra Lifesciences Holdings ranks worse than 64.17% on this metric.
The historical rank and industry rank for Integra Lifesciences Holdings's Days Inventory or its related term are showing as below:
IART'
s Days Inventory Range Over the Past 10 Years
Min: 184.16 Med: 202.29 Max: 224.12
Current: 220.51
During the past 13 years, Integra Lifesciences Holdings's highest Days Inventory was 224.12. The lowest was 184.16. And the median was 202.29.
IART's Days Inventory is ranked worse than 64.17% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 179.47
vs IART: 220.51
Inventory Turnover measures how fast the company turns over its inventory within a year.
Integra Lifesciences Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.35.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Integra Lifesciences Holdings's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.26.
Integra Lifesciences Holdings (NAS:IART) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Integra Lifesciences Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Integra Lifesciences Holdings's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Integra Lifesciences Holdings Days Inventory Related Terms
Integra Lifesciences Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integra Lifesciences Holdings Days Inventory Chart
IART vs ATEC, AHCO, INSP: Days Inventory Comparison
For the Medical Devices subindustry, Integra Lifesciences Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integra Lifesciences Holdings Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Integra Lifesciences Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Integra Lifesciences Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integra Lifesciences Holdings (IART) has a Days Inventory of 257.62 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Integra Lifesciences Holdings and its competitors. This is 27% above median its historical median of 202.29. Over the past decade, Integra Lifesciences Holdings' Days Inventory has ranged from 184.16 to 224.12. According to the industry distribution chart, Integra Lifesciences Holdings ranks #505 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 64.2%.
Is Integra Lifesciences Holdings' Days Inventory too high?
Integra Lifesciences Holdings' current Days Inventory of 257.62 is 27% above median its 10-year median of 202.29. Over the past 10 years, this metric has ranged from a low of 184.16 to a high of 224.12. The Medical Devices & Instruments industry median Days Inventory is 179.47. Integra Lifesciences Holdings' value of 257.62 is 43.5% above this industry median. Based on the distribution chart, Integra Lifesciences Holdings ranks #505 out of 787 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Integra Lifesciences Holdings has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integra Lifesciences Holdings' Days Inventory compare to ATEC and AHCO?
According to the Medical Devices & Instruments industry distribution chart, Integra Lifesciences Holdings ranks #505 out of 787 companies for Days Inventory. This places Integra Lifesciences Holdings in the lower half of its industry. The industry median Days Inventory is 179.47. Integra Lifesciences Holdings' value of 257.62 is 43.5% above this benchmark. Historically, Integra Lifesciences Holdings' own Days Inventory has ranged from 184.16 to 224.12 over the past decade. While the company's 10-year median is 202.29 vs. the industry median of 179.47, Integra Lifesciences Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.47, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integra Lifesciences Holdings's current Days Inventory of 257.62 is 43.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Integra Lifesciences Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integra Lifesciences Holdings's current Days Inventory is 257.62, which is 27% above median its own 10-year median of 202.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integra Lifesciences Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integra Lifesciences Holdings (IART) is currently considered Modestly Undervalued. The stock's GF Value™ is $23.81, compared to a current price of $18.78 — trading 21.1% below its estimated fair value. The current Days Inventory is 257.62, which is 27% above median its 10-year median of 202.29 and 43.5% above the Medical Devices & Instruments industry median of 179.47. Integra Lifesciences Holdings' overall GF Score™ is 70/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Integra Lifesciences Holdings (IART), the current Days Inventory is 257.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integra Lifesciences Holdings (IART) Overvalued in 2026?
Based on GuruFocus' analysis, Integra Lifesciences Holdings stock appears to be undervalued.
The current stock price of $18.78 is trading 21.1% below its estimated GF Value™ of $23.81.
GuruFocus considers Integra Lifesciences Holdings to be Modestly Undervalued.
Key valuation signals for IART:
Days Inventory: 257.62 (27% above median its 10-year median of 202.29)
GF Value™: $23.81 vs. price of $18.78 (21.1% below fair value)
Industry Position: 43.5% above the Medical Devices & Instruments median (#505 of 787)
No single metric tells the full story. See the IART stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integra Lifesciences Holdings Business Description
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
70GF Score
Get the complete analysis for IART
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IART has been successfully added to your 
